05/09/2024
4:01 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:06 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:35 PM | ADMA Biologics (Filer)
| Form DEFA14A | |
04/15/2024
3:40 PM | ADMA Biologics (Filer)
| Form ARS | |
04/15/2024
3:31 PM | ADMA Biologics (Filer)
| Form DEF 14A | |
04/02/2024
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/02/2024
8:01 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
8:48 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
8:00 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:44 PM | ADMA Biologics (Subject)
Aisling Capital II LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
11:31 AM | ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
| Form SC 13G/A | |
03/11/2024
11:24 AM | ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
03/11/2024
11:19 AM | ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
| Form SC 13G/A | |
03/08/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
8:01 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Fong Bryant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:15 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:21 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
8:03 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:00 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
10:47 AM | ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
| Form SC 13G | |
02/14/2024
10:50 AM | ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
| Form SC 13G | |
02/14/2024
10:37 AM | ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
| Form SC 13G | |
01/08/2024
7:00 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:30 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:30 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
3:30 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
3:31 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The 2024 Gold Rush: Unleashing Market Potential (Ad) Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. |
10/03/2023
8:02 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:45 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
3:46 PM | ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/24/2023
6:53 PM | ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
7:30 PM | ADMA Biologics (Issuer)
Fong Bryant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
4:09 PM | ADMA Biologics (Subject)
Fong Bryant (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
8:46 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
8:30 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
8:30 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
7:50 PM | ADMA Biologics (Subject)
LENZ BRIAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
7:47 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023
6:30 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
3:30 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2023
6:30 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2023
6:31 AM | ADMA Biologics (Filer)
| Form DEFA14A | |
